Paperpal Prime Logo

DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE : Impact Factor & More

eISSN: 1179-9900pISSN: 1179-9900
Recommended pre-submission checks
Powered by Paperpal by Editage

DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE

Marked Clinical Improvement in Parkinson\u2019s Disease Following Double-Filtration Apheresis: A Case Report
  • 12 Jun 2026
  • Degenerative Neurological and Neuromuscular Disease
Spermidine in Alzheimer’s Disease: Evidence from Animal Models and Human Studies
  • 1 Jun 2026
  • Degenerative Neurological and Neuromuscular Disease
(Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective
  • 20 May 2026
  • Degenerative Neurological and Neuromuscular Disease
Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program.
  • 1 Apr 2026
  • Degenerative neurological and neuromuscular disease
Agreement and Comparative Performance of Cognitive Testing, Visual MRI Rating, and Automated Brain Morphometry in Older Adults with Suspected Dementia in Uganda.
  • 1 Apr 2026
  • Degenerative neurological and neuromuscular disease
Advancements in Therapy for Alzheimer’s Disease Based on the Cerebral Lymphatic System
  • 31 Jan 2026
  • Degenerative Neurological and Neuromuscular Disease
Marked Clinical Improvement in Parkinson\u2019s Disease Following Double-Filtration Apheresis: A Case Report
  • 12 Jun 2026
  • Degenerative Neurological and Neuromuscular Disease
Spermidine in Alzheimer’s Disease: Evidence from Animal Models and Human Studies
  • 1 Jun 2026
  • Degenerative Neurological and Neuromuscular Disease
(Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective
  • 20 May 2026
  • Degenerative Neurological and Neuromuscular Disease
Effectiveness of Siponimod with Up to 2 Years of Treatment in a Real-World Setting in People with SPMS: Analysis from the Novartis Global Managed Access Program.
  • 1 Apr 2026
  • Degenerative neurological and neuromuscular disease
Agreement and Comparative Performance of Cognitive Testing, Visual MRI Rating, and Automated Brain Morphometry in Older Adults with Suspected Dementia in Uganda.
  • 1 Apr 2026
  • Degenerative neurological and neuromuscular disease
Advancements in Therapy for Alzheimer’s Disease Based on the Cerebral Lymphatic System
  • 31 Jan 2026
  • Degenerative Neurological and Neuromuscular Disease

FAQs on DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE